This test is most useful if any of these apply to you.
Your body makes dopamine in your brain, your gut, and parts of your nervous system. When dopamine gets used up, it gets broken down into HVA (homovanillic acid), which then leaves your body through your urine. Measuring how much HVA shows up in your urine gives you a window into how actively your dopamine system is turning over.
This is a research-grade marker without standardized adult cutpoints, but it has clear clinical uses in specific situations and is increasingly studied in adult conditions like Parkinson's disease, gut dysbiosis, and chronic stress. Knowing your level gives you a baseline you can track over time.
Dopamine is built from the amino acid tyrosine, then broken down by two enzymes that turn it step by step into HVA. The HVA leaves your body mostly through your kidneys. That means urinary HVA reflects a mix of three things: how much dopamine your body is making, how actively that dopamine is being used and broken down, and how well your kidneys are clearing the final product.
Sources of HVA in your urine include brain dopamine neurons, sympathetic nerves and the adrenal glands, and gut microbes that can also produce HVA. About half of HVA formed in the body is eliminated through routes other than the kidneys, which is one reason urine HVA captures only part of total dopamine turnover.
The longest-standing clinical use of urinary HVA is detecting tumors that overproduce catecholamines, most notably neuroblastoma in children. In adults, the most relevant tumor is pheochromocytoma, where urinary free metanephrines are usually the preferred test, but HVA can still rise.
When HVA is paired with a related metabolite called VMA (vanillylmandelic acid), the combination catches a large share of neuroblastoma cases in pediatric studies. In one study, HVA alone using a defined cutoff had a sensitivity of about 0.83 and specificity near 1.00 for neuroblastoma diagnosis. Adding more catecholamine metabolites (an eight-marker panel) pushed sensitivity to about 95 percent while reducing specificity. A separate study of plasma 3-methoxytyramine plus normetanephrine reached roughly 97.9 percent sensitivity and 95.1 percent specificity, outperforming urine HVA and VMA in that comparison. These figures are derived from pediatric neuroblastoma research and may not translate directly to adult use.
What this means for you: if your urinary HVA comes back elevated, the next step is not to panic but to retest and order companion markers like VMA, metanephrines, and normetanephrine. A pattern of multiple elevated catecholamine markers warrants a visit to an endocrinologist for tumor workup. A single mildly elevated HVA with everything else normal often points to diet, medications, or natural variation rather than disease.
In a pilot study of 40 people, urinary HVA was elevated in those with Parkinson's disease compared with controls. The signal here is mixed: higher urinary HVA can reflect more active dopamine metabolism during levodopa therapy (a common Parkinson's medication), and it may also reflect contributions from altered gut microbes. This finding is exploratory, not a diagnostic test for Parkinson's.
In a study of 60 adults with functional constipation, urinary HVA was higher than in controls, and the ratio of HVA to 5-HIAA (a serotonin breakdown product) correlated with both gut imbalance and symptom severity. The picture that emerges is one where dopamine metabolism and the gut microbiome are linked, and urinary HVA may serve as a non-invasive window into that gut-brain conversation.
In a study of 100 workers, those classified as high-stress had lower urinary HVA and lower urinary dopamine than low-stress peers. The researchers built a composite stress index using these markers. The takeaway is not that low HVA means stress, but that urinary catecholamine markers, including HVA, vary with psychological state in ways that are still being mapped out.
In a separate study of 21 girls who had experienced sexual abuse, urinary HVA and other catecholamine metabolites were higher than in controls, interpreted as evidence of heightened catecholamine system activity. These findings are research-grade signals, not diagnostic tools, and they show that HVA reflects sustained nervous system tone, not just specific diseases.
Reading the studies above, you might notice an apparent contradiction: chronic worker stress lowered urinary HVA, while abuse-related stress raised it. This is not a paradox once you understand the framing. HVA is a turnover marker, not a good-or-bad number. Different types of stress, different durations, and different populations can push dopamine handling in different directions. That is why a single HVA reading carries limited meaning on its own and why context, companion markers, and trends matter more than any one snapshot.
In a study of 40 children undergoing cardiac surgery, an early rise in a sulfated form of urinary HVA predicted later acute kidney injury with high sensitivity and specificity. This is a pediatric finding in a very specific setting, but it illustrates a broader point: HVA clearance depends on functioning kidneys, and changes in clearance can either reflect kidney problems or distort the picture of what is happening with dopamine itself.
Because HVA is a research-grade marker without standardized adult cutpoints, a single value tells you very little. What matters is your personal baseline and how it moves over time. HVA swings in response to diet, medications, stress, and gut microbiome changes, so a one-time reading can mislead you in either direction.
Get a baseline now. If you are making lifestyle changes or starting a new medication that could affect dopamine metabolism, retest in 3 to 6 months. After that, an annual measurement gives you a trajectory you can interpret in context with your other markers. Watch whether HVA moves alongside related tests like VMA or metanephrines, because patterns across multiple markers are far more informative than any single number.
Several common factors can distort a single urinary HVA reading without changing your underlying biology:
Urinary HVA is usually reported relative to creatinine to correct for how dilute or concentrated your urine is. For best comparability across tests, collect at a consistent time of day, avoid heavy monoamine-rich foods (bananas, citrus, nuts, chocolate, vanilla, olives) for 48 hours beforehand, and note any medications you are taking. If you are doing serial testing, repeat the same protocol each time.
If your HVA comes back unusually high or low, your first move is to retest with a clean protocol (consistent timing, no interfering foods or medications). If a second reading confirms the change, consider companion tests: urinary VMA, urinary metanephrines, and plasma free metanephrines together give a much fuller picture of catecholamine activity. A pattern of multiple elevated catecholamine markers warrants evaluation by an endocrinologist. Persistent elevations alongside neurological symptoms suggest involving a neurologist. If results are normal but you have specific concerns (Parkinson's risk, persistent gut symptoms, chronic stress), HVA is best used as part of a broader workup rather than a stand-alone test.
Evidence-backed interventions that affect your Homovanillic Acid (HVA) level
Homovanillic Acid (HVA) is best interpreted alongside these tests.
Homovanillic Acid (HVA) is included in these pre-built panels.